Dohmen K, Nagano M, Iwakiri R, Yamano Y, Kikuchi Y, Mizoguchi M, Iwata Y, Mori Y, Ishibashi H
Department of Internal Medicine, Kyushu Koseinenkin Hospital, Kitakyushu, Japan.
Gastroenterol Jpn. 1991 Jun;26(3):376-81. doi: 10.1007/BF02781928.
We report a case of lambda-AL amyloidosis which manifested prominent hepatic cholestasis. The patient was a 71-year-old Japanese male who was admitted to our hospital because of abdominal distension and jaundice. Laboratory examination revealed a marked deterioration of liver function with cholestasis. Gastric biopsy revealed amyloid deposition. Under a diagnosis of primary amyloidosis he was treated with corticosteroid and dimethylsulfoxide. However, jaundice progressed, renal function deteriorated rapidly, and he died two weeks after admission. Autopsy revealed a profound deposition of lambda-AL amyloid not only in the liver but also in the kidneys, spleen, lungs, heart and intestine.